Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nuclear Medicine & Radiopharmaceuticals market size was valued at US$ million in 2023. With growing demand in downstream market, the Nuclear Medicine & Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nuclear Medicine & Radiopharmaceuticals market. Nuclear Medicine & Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nuclear Medicine & Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nuclear Medicine & Radiopharmaceuticals market.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
Key Features:
The report on Nuclear Medicine & Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nuclear Medicine & Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Diagnostic, Therapeutic), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nuclear Medicine & Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nuclear Medicine & Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nuclear Medicine & Radiopharmaceuticals industry. This include advancements in Nuclear Medicine & Radiopharmaceuticals technology, Nuclear Medicine & Radiopharmaceuticals new entrants, Nuclear Medicine & Radiopharmaceuticals new investment, and other innovations that are shaping the future of Nuclear Medicine & Radiopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nuclear Medicine & Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Nuclear Medicine & Radiopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nuclear Medicine & Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nuclear Medicine & Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nuclear Medicine & Radiopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nuclear Medicine & Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nuclear Medicine & Radiopharmaceuticals market.
Market Segmentation:
Nuclear Medicine & Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Nuclear Medicine & Radiopharmaceuticals market?
What factors are driving Nuclear Medicine & Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine & Radiopharmaceuticals market opportunities vary by end market size?
How does Nuclear Medicine & Radiopharmaceuticals break out type, application?
According to our LPI (LP Information) latest study, the global Nuclear Medicine & Radiopharmaceuticals market size was valued at US$ million in 2023. With growing demand in downstream market, the Nuclear Medicine & Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nuclear Medicine & Radiopharmaceuticals market. Nuclear Medicine & Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nuclear Medicine & Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nuclear Medicine & Radiopharmaceuticals market.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
Key Features:
The report on Nuclear Medicine & Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nuclear Medicine & Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Diagnostic, Therapeutic), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nuclear Medicine & Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nuclear Medicine & Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nuclear Medicine & Radiopharmaceuticals industry. This include advancements in Nuclear Medicine & Radiopharmaceuticals technology, Nuclear Medicine & Radiopharmaceuticals new entrants, Nuclear Medicine & Radiopharmaceuticals new investment, and other innovations that are shaping the future of Nuclear Medicine & Radiopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nuclear Medicine & Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Nuclear Medicine & Radiopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nuclear Medicine & Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nuclear Medicine & Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nuclear Medicine & Radiopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nuclear Medicine & Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nuclear Medicine & Radiopharmaceuticals market.
Market Segmentation:
Nuclear Medicine & Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Diagnostic
- Therapeutic
- Oncology
- Thyroid
- Cardiology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
What is the 10-year outlook for the global Nuclear Medicine & Radiopharmaceuticals market?
What factors are driving Nuclear Medicine & Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine & Radiopharmaceuticals market opportunities vary by end market size?
How does Nuclear Medicine & Radiopharmaceuticals break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Country/Region, 2019, 2023 & 2030
2.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Type
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2019-2024)
2.4 Nuclear Medicine & Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Medicine & Radiopharmaceuticals Sales by Application
2.5.1 Global Nuclear Medicine & Radiopharmaceuticals Sale Market Share by Application (2019-2024)
2.5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2019-2024)
3 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY COMPANY
3.1 Global Nuclear Medicine & Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Company (2019-2024)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2019-2024)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Company (2019-2024)
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2019-2024)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2019-2024)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Location Distribution
3.4.2 Players Nuclear Medicine & Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Geographic Region (2019-2024)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Country/Region (2019-2024)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.4 APAC Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.5 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country
5.1.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024)
5.1.2 Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024)
5.2 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type
5.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region
6.1.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019-2024)
6.1.2 APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2019-2024)
6.2 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type
6.3 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine & Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024)
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024)
7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type
7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024)
8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine & Radiopharmaceuticals Distributors
11.3 Nuclear Medicine & Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Region (2025-2030)
12.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Type
12.7 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 China Isotope & Radiation
13.1.1 China Isotope & Radiation Company Information
13.1.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 China Isotope & Radiation Main Business Overview
13.1.5 China Isotope & Radiation Latest Developments
13.2 Dongcheng
13.2.1 Dongcheng Company Information
13.2.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Dongcheng Main Business Overview
13.2.5 Dongcheng Latest Developments
13.3 Jaco
13.3.1 Jaco Company Information
13.3.2 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jaco Main Business Overview
13.3.5 Jaco Latest Developments
13.4 Ciaeriar
13.4.1 Ciaeriar Company Information
13.4.2 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ciaeriar Main Business Overview
13.4.5 Ciaeriar Latest Developments
13.5 Advanced Molecular-imaging Solution
13.5.1 Advanced Molecular-imaging Solution Company Information
13.5.2 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Advanced Molecular-imaging Solution Main Business Overview
13.5.5 Advanced Molecular-imaging Solution Latest Developments
13.6 Shanghai Atom Kexing
13.6.1 Shanghai Atom Kexing Company Information
13.6.2 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shanghai Atom Kexing Main Business Overview
13.6.5 Shanghai Atom Kexing Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Country/Region, 2019, 2023 & 2030
2.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Type
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2019-2024)
2.4 Nuclear Medicine & Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Medicine & Radiopharmaceuticals Sales by Application
2.5.1 Global Nuclear Medicine & Radiopharmaceuticals Sale Market Share by Application (2019-2024)
2.5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2019-2024)
3 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY COMPANY
3.1 Global Nuclear Medicine & Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Company (2019-2024)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2019-2024)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Company (2019-2024)
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2019-2024)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2019-2024)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Location Distribution
3.4.2 Players Nuclear Medicine & Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Geographic Region (2019-2024)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Country/Region (2019-2024)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.4 APAC Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.5 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country
5.1.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024)
5.1.2 Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024)
5.2 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type
5.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region
6.1.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019-2024)
6.1.2 APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2019-2024)
6.2 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type
6.3 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine & Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024)
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024)
7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type
7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024)
8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine & Radiopharmaceuticals Distributors
11.3 Nuclear Medicine & Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE & RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Region (2025-2030)
12.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Type
12.7 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 China Isotope & Radiation
13.1.1 China Isotope & Radiation Company Information
13.1.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 China Isotope & Radiation Main Business Overview
13.1.5 China Isotope & Radiation Latest Developments
13.2 Dongcheng
13.2.1 Dongcheng Company Information
13.2.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Dongcheng Main Business Overview
13.2.5 Dongcheng Latest Developments
13.3 Jaco
13.3.1 Jaco Company Information
13.3.2 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jaco Main Business Overview
13.3.5 Jaco Latest Developments
13.4 Ciaeriar
13.4.1 Ciaeriar Company Information
13.4.2 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ciaeriar Main Business Overview
13.4.5 Ciaeriar Latest Developments
13.5 Advanced Molecular-imaging Solution
13.5.1 Advanced Molecular-imaging Solution Company Information
13.5.2 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Advanced Molecular-imaging Solution Main Business Overview
13.5.5 Advanced Molecular-imaging Solution Latest Developments
13.6 Shanghai Atom Kexing
13.6.1 Shanghai Atom Kexing Company Information
13.6.2 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shanghai Atom Kexing Main Business Overview
13.6.5 Shanghai Atom Kexing Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diagnostic
Table 4. Major Players of Therapeutic
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2019-2024)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Nuclear Medicine & Radiopharmaceuticals Sales by Company (2019-2024) & (K Units)
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2019-2024)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2019-2024)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Nuclear Medicine & Radiopharmaceuticals Products Offered
Table 22. Nuclear Medicine & Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 34. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2019-2024)
Table 35. Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 38. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 39. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 40. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 41. APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 43. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 44. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 45. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 46. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2019-2024)
Table 47. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 49. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 50. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceuticals
Table 58. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceuticals
Table 59. Key Industry Trends of Nuclear Medicine & Radiopharmaceuticals
Table 60. Nuclear Medicine & Radiopharmaceuticals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 63. Nuclear Medicine & Radiopharmaceuticals Customer List
Table 64. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 80. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. China Isotope & Radiation Main Business
Table 82. China Isotope & Radiation Latest Developments
Table 83. Dongcheng Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 85. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Dongcheng Main Business
Table 87. Dongcheng Latest Developments
Table 88. Jaco Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Jaco Main Business
Table 92. Jaco Latest Developments
Table 93. Ciaeriar Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Ciaeriar Main Business
Table 97. Ciaeriar Latest Developments
Table 98. Advanced Molecular-imaging Solution Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Advanced Molecular-imaging Solution Main Business
Table 102. Advanced Molecular-imaging Solution Latest Developments
Table 103. Shanghai Atom Kexing Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Shanghai Atom Kexing Main Business
Table 107. Shanghai Atom Kexing Latest Developments
Table 1. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diagnostic
Table 4. Major Players of Therapeutic
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2019-2024)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Nuclear Medicine & Radiopharmaceuticals Sales by Company (2019-2024) & (K Units)
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2019-2024)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2019-2024)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Nuclear Medicine & Radiopharmaceuticals Products Offered
Table 22. Nuclear Medicine & Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 34. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2019-2024)
Table 35. Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 38. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 39. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 40. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 41. APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 43. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 44. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 45. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 46. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2019-2024)
Table 47. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 49. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 50. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceuticals
Table 58. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceuticals
Table 59. Key Industry Trends of Nuclear Medicine & Radiopharmaceuticals
Table 60. Nuclear Medicine & Radiopharmaceuticals Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 63. Nuclear Medicine & Radiopharmaceuticals Customer List
Table 64. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 80. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. China Isotope & Radiation Main Business
Table 82. China Isotope & Radiation Latest Developments
Table 83. Dongcheng Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 85. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Dongcheng Main Business
Table 87. Dongcheng Latest Developments
Table 88. Jaco Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Jaco Main Business
Table 92. Jaco Latest Developments
Table 93. Ciaeriar Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Ciaeriar Main Business
Table 97. Ciaeriar Latest Developments
Table 98. Advanced Molecular-imaging Solution Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Advanced Molecular-imaging Solution Main Business
Table 102. Advanced Molecular-imaging Solution Latest Developments
Table 103. Shanghai Atom Kexing Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Shanghai Atom Kexing Main Business
Table 107. Shanghai Atom Kexing Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Diagnostic
Figure 10. Product Picture of Therapeutic
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2023
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Figure 13. Nuclear Medicine & Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market: Oncology (2019-2024) & (K Units)
Figure 15. Nuclear Medicine & Radiopharmaceuticals Consumed in Thyroid
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Market: Thyroid (2019-2024) & (K Units)
Figure 17. Nuclear Medicine & Radiopharmaceuticals Consumed in Cardiology
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Market: Cardiology (2019-2024) & (K Units)
Figure 19. Nuclear Medicine & Radiopharmaceuticals Consumed in Others
Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Market: Others (2019-2024) & (K Units)
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2023)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2023
Figure 23. Nuclear Medicine & Radiopharmaceuticals Sales Market by Company in 2023 (K Units)
Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company in 2023
Figure 25. Nuclear Medicine & Radiopharmaceuticals Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company in 2023
Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 30. Americas Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 31. APAC Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 32. APAC Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 33. Europe Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 38. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2023
Figure 39. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 40. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 41. United States Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2023
Figure 46. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2023
Figure 47. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 48. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 49. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 57. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2023
Figure 58. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 59. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 60. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 69. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2023
Figure 75. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 76. Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
Figure 77. Channels of Distribution
Figure 78. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Forecast by Region (2025-2030)
Figure 79. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nuclear Medicine & Radiopharmaceuticals Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Diagnostic
Figure 10. Product Picture of Therapeutic
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2023
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2019-2024)
Figure 13. Nuclear Medicine & Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market: Oncology (2019-2024) & (K Units)
Figure 15. Nuclear Medicine & Radiopharmaceuticals Consumed in Thyroid
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Market: Thyroid (2019-2024) & (K Units)
Figure 17. Nuclear Medicine & Radiopharmaceuticals Consumed in Cardiology
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Market: Cardiology (2019-2024) & (K Units)
Figure 19. Nuclear Medicine & Radiopharmaceuticals Consumed in Others
Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Market: Others (2019-2024) & (K Units)
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2023)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2023
Figure 23. Nuclear Medicine & Radiopharmaceuticals Sales Market by Company in 2023 (K Units)
Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company in 2023
Figure 25. Nuclear Medicine & Radiopharmaceuticals Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company in 2023
Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 30. Americas Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 31. APAC Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 32. APAC Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 33. Europe Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2024 ($ Millions)
Figure 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 38. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2023
Figure 39. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 40. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 41. United States Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2023
Figure 46. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2023
Figure 47. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 48. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 49. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 57. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2023
Figure 58. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 59. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 60. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 69. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2023
Figure 75. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 76. Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
Figure 77. Channels of Distribution
Figure 78. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Forecast by Region (2025-2030)
Figure 79. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2025-2030)
